CY1114161T1 - ENZYMAL INHIBITION COMPOUNDS - Google Patents
ENZYMAL INHIBITION COMPOUNDSInfo
- Publication number
- CY1114161T1 CY1114161T1 CY20131100619T CY131100619T CY1114161T1 CY 1114161 T1 CY1114161 T1 CY 1114161T1 CY 20131100619 T CY20131100619 T CY 20131100619T CY 131100619 T CY131100619 T CY 131100619T CY 1114161 T1 CY1114161 T1 CY 1114161T1
- Authority
- CY
- Cyprus
- Prior art keywords
- peptide
- based compounds
- enzymal
- terminal
- proteasome
- Prior art date
Links
Abstract
Ενώσεις με πεπτιδική βάση περιέχουσες τριμελείς δακτυλίους που περιέχουν ετεροάτομο αναστέλλουν αποτελεσματικά και επιλεκτικά ειδικές δραστικότητες Ν-τερματικών πυρηνόφιλων (Ntn)υδρολασών συνδεομένων με το πρωτεάσωμα. Στις ενώσεις με πεπτιδική βάση περιέχονται ένα εποξείδιο ή αζιριδίνη, και δραστική ομάδα στο τερματικό Ν. Μεταξύ άλλων θεραπευτικών χρησιμοτήτων, οι ενώσεις με πεπτιδική βάση αναμένεται να επιδεικνύουν αντιφλεγμονώδεις ιδιότητες και αναστολή του κυτταρικού πολλαπλασιασμού. Η από στόματος χορήγηση αυτών των αναστολέων πρωτεασώματος με πεπτιδική βάση είναι δυνατή λόγω των ιδιοτήτων βιοδιαθεσιμότητάς τους.Peptide-based compounds containing heteroatom-containing three-membered rings effectively and selectively inhibit specific activities of N-terminal nucleophilic (Ntn) hydrolases bound to the proteasome. The peptide-based compounds contain an epoxide or aziridine, and a functional group at the N. terminal. Among other therapeutic uses, the peptide-based compounds are expected to exhibit anti-inflammatory properties and inhibit cell proliferation. Oral administration of these peptide-based proteasome inhibitors is possible due to their bioavailability properties.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73611805A | 2005-11-09 | 2005-11-09 | |
US84258206A | 2006-09-05 | 2006-09-05 | |
EP06837164.0A EP1948678B1 (en) | 2005-11-09 | 2006-11-09 | Compounds for enzyme inhibition |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1114161T1 true CY1114161T1 (en) | 2016-08-31 |
Family
ID=58436436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100619T CY1114161T1 (en) | 2005-11-09 | 2013-07-23 | ENZYMAL INHIBITION COMPOUNDS |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1114161T1 (en) |
-
2013
- 2013-07-23 CY CY20131100619T patent/CY1114161T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119405T1 (en) | UNION FOR SUSPENSION OF ENZYMES | |
CY1120677T1 (en) | COMPOUNDS FOR PROTOSOME ENZYME INHIBITION | |
CY1115605T1 (en) | COMPOUNDS FOR THE INHIBITION OF THE PROTOMASE ENZYME | |
ECSP20027480A (en) | INDOLIL ALKYL AMINO DERIVATIVES SUBSTITUTED AS NEW INHIBITORS OF HISTONE DESACETILASE | |
DE602005025750D1 (en) | COMPOUNDS FOR PROTEASOME CYCLING | |
WO2008140782A3 (en) | Compounds for enzyme inhibition | |
EA200401526A1 (en) | NEW CONNECTIONS AND THEIR APPLICATION | |
UY28572A1 (en) | NEW COMPOUNDS | |
CY1113560T1 (en) | AZAndolia Useful as Suspensions of JAK and Other Protein Kinases | |
IS7965A (en) | Thienopyrimidinedione and their use in the development of self-hypersensitivity disease | |
BRPI0417717A (en) | compound, pharmaceutical composition, and use of a compound | |
CY1110419T1 (en) | Tricyclic compounds based on 1,6-dihydro-1,3,5,6-TETPAAZA-AS-INDAKENE and PHARMACEUTICAL COMPOSITIONS CONTAINING AS INCORRECT | |
BRPI0908120A8 (en) | COMPOUNDS WHICH ARE ERK INHIBITORS, PHARMACEUTICAL COMPOSITION AND USE | |
EA201170441A1 (en) | THERAPEUTIC ANTI-VIRAL PEPTIDES | |
EA200702058A1 (en) | NEW PHARMACEUTICAL COMPOUNDS | |
UY27851A1 (en) | DIFENILAZETIDINONAS REPLACED IN RING, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE. | |
BRPI0517033A (en) | novel hydantoin derivatives as metalloproteinase inhibitors | |
BRPI0409276A (en) | piperazine derivatives renin inhibitors | |
UY30801A1 (en) | CALCILITICAL COMPOUNDS | |
NI200700176A (en) | PEPTIDE COMPOUNDS | |
CY1114161T1 (en) | ENZYMAL INHIBITION COMPOUNDS | |
CY1108396T1 (en) | NON-NUCLEOZITIC REVERSAL TRANSFERRATION INFLUENCES AS COMPONENTS OF CELL CULTIVATION AND DIFFERENCE DIFFERENCES | |
BRPI0406893A (en) | Acylaminothiazole derivatives, their preparation and their use as inhibitors of betaamyloid peptide production | |
BRPI0510306A (en) | hiv integrase enzyme inhibitors, pharmaceutical composition containing said inhibitors as well as their use | |
DE602004010667D1 (en) | CYTOTOXIC DEPSIPEPTIDES |